327 related articles for article (PubMed ID: 25344904)
21. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
22. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.
Kim J; Choi JY; Park SH; Yang SH; Park JA; Shin K; Lee EY; Kawachi H; Kohsaka H; Song YW
Arthritis Res Ther; 2014 Jun; 16(3):R126. PubMed ID: 24939012
[TBL] [Abstract][Full Text] [Related]
24. T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.
Hu J; Sun C; Bernatchez C; Xia X; Hwu P; Dotti G; Li S
Clin Cancer Res; 2018 Jun; 24(12):2920-2934. PubMed ID: 29391351
[No Abstract] [Full Text] [Related]
25. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
[TBL] [Abstract][Full Text] [Related]
26. A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy.
Muenchmeier N; Boecker S; Bankel L; Hinz L; Rieth N; Lapa C; Mendler AN; Noessner E; Mocikat R; Nelson PJ
PLoS One; 2013; 8(8):e72749. PubMed ID: 24023642
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC
Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M
Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006
[TBL] [Abstract][Full Text] [Related]
28. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone.
Sentman CL; Meadows SK; Wira CR; Eriksson M
J Immunol; 2004 Dec; 173(11):6760-6. PubMed ID: 15557169
[TBL] [Abstract][Full Text] [Related]
29. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition.
Singh UP; Singh S; Singh R; Cong Y; Taub DD; Lillard JW
J Interferon Cytokine Res; 2008 Jan; 28(1):31-43. PubMed ID: 18370870
[TBL] [Abstract][Full Text] [Related]
30. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
Jiang D; Liang J; Hodge J; Lu B; Zhu Z; Yu S; Fan J; Gao Y; Yin Z; Homer R; Gerard C; Noble PW
J Clin Invest; 2004 Jul; 114(2):291-9. PubMed ID: 15254596
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
32. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
33. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
[TBL] [Abstract][Full Text] [Related]
34. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
Saudemont A; Jouy N; Hetuin D; Quesnel B
Blood; 2005 Mar; 105(6):2428-35. PubMed ID: 15536145
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10.
Zhang Y; Gao Z; Wang D; Zhang T; Sun B; Mu L; Wang J; Liu Y; Kong Q; Liu X; Zhang Y; Zhang H; He J; Li H; Wang G
J Neuroinflammation; 2014 Apr; 11():79. PubMed ID: 24742325
[TBL] [Abstract][Full Text] [Related]
36. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs.
Wald O; Weiss ID; Wald H; Shoham H; Bar-Shavit Y; Beider K; Galun E; Weiss L; Flaishon L; Shachar I; Nagler A; Lu B; Gerard C; Gao JL; Mishani E; Farber J; Peled A
J Immunol; 2006 Apr; 176(8):4716-29. PubMed ID: 16585565
[TBL] [Abstract][Full Text] [Related]
37. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
38. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
[TBL] [Abstract][Full Text] [Related]
39. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock.
Herzig DS; Driver BR; Fang G; Toliver-Kinsky TE; Shute EN; Sherwood ER
Am J Respir Crit Care Med; 2012 Feb; 185(3):291-300. PubMed ID: 22135342
[TBL] [Abstract][Full Text] [Related]
40. LINC00152 mediates CD8
Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
